Jacobs Levy Equity Management Inc. Invests $4.30 Million in The Beauty Health Company (NASDAQ:SKIN)

Jacobs Levy Equity Management Inc. acquired a new position in shares of The Beauty Health Company (NASDAQ:SKIN) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 967,755 shares of the company’s stock, valued at approximately $4,297,000. Jacobs Levy Equity Management Inc. owned about 0.78% of Beauty Health at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Raymond James & Associates acquired a new position in shares of Beauty Health in the fourth quarter valued at approximately $31,000. Sierra Summit Advisors LLC purchased a new position in Beauty Health in the fourth quarter worth approximately $856,000. Mirae Asset Global Investments Co. Ltd. purchased a new position in Beauty Health in the first quarter worth approximately $200,000. Global Retirement Partners LLC lifted its stake in Beauty Health by 359.5% in the fourth quarter. Global Retirement Partners LLC now owns 119,023 shares of the company’s stock worth $370,000 after acquiring an additional 93,123 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. purchased a new position in Beauty Health in the fourth quarter worth approximately $31,000. 93.26% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages recently issued reports on SKIN. Piper Sandler decreased their price target on shares of Beauty Health from $2.50 to $1.50 and set an “underweight” rating for the company in a research note on Thursday, July 11th. DA Davidson reiterated a “buy” rating and issued a $5.00 price target on shares of Beauty Health in a research note on Monday, May 13th. TD Cowen reduced their price objective on shares of Beauty Health from $4.00 to $3.00 and set a “hold” rating for the company in a research report on Monday, May 13th. Finally, Stifel Nicolaus reduced their price objective on shares of Beauty Health from $4.00 to $2.00 and set a “hold” rating for the company in a research report on Friday, July 26th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $5.86.

Beauty Health Stock Performance

Shares of Beauty Health stock traded up $0.12 during trading on Wednesday, reaching $1.92. The company’s stock had a trading volume of 187,433 shares, compared to its average volume of 2,119,355. The company has a 50-day moving average price of $2.00 and a two-hundred day moving average price of $2.86. The firm has a market cap of $237.37 million, a PE ratio of -2.64 and a beta of 0.96. The Beauty Health Company has a fifty-two week low of $1.35 and a fifty-two week high of $8.36. The company has a current ratio of 6.57, a quick ratio of 5.55 and a debt-to-equity ratio of 10.51.

Beauty Health (NASDAQ:SKIN) last announced its earnings results on Thursday, May 9th. The company reported ($0.10) EPS for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.04. The business had revenue of $81.40 million for the quarter, compared to analysts’ expectations of $80.56 million. Beauty Health had a negative net margin of 20.48% and a negative return on equity of 0.02%. The company’s quarterly revenue was down 5.7% on a year-over-year basis. During the same period in the previous year, the company posted ($0.17) EPS. On average, analysts forecast that The Beauty Health Company will post -0.08 EPS for the current year.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.